These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36460868)

  • 21. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.
    Moo-Young TA; Larson JW; Belt BA; Tan MC; Hawkins WG; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunother; 2009 Jan; 32(1):12-21. PubMed ID: 19307989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.
    Barao I; Hanash AM; Hallett W; Welniak LA; Sun K; Redelman D; Blazar BR; Levy RB; Murphy WJ
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5460-5. PubMed ID: 16567639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice.
    Kan X; Zhang W; You R; Niu Y; Guo J; Xue J
    BMC Complement Altern Med; 2017 Jan; 17(1):41. PubMed ID: 28086772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen.
    Roy S; Barnes PF; Garg A; Wu S; Cosman D; Vankayalapati R
    J Immunol; 2008 Feb; 180(3):1729-36. PubMed ID: 18209070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
    Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
    Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression.
    Cho J; Kim SJ; Park WY; Kim J; Woo J; Kim G; Yoon SE; Ko YH; Kim WS
    Mod Pathol; 2020 Apr; 33(4):603-615. PubMed ID: 31653980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
    Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
    J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation.
    Wang H; Li S; Zhang G; Wu H; Chang X
    Arthritis Res Ther; 2019 Oct; 21(1):220. PubMed ID: 31661005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
    Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
    Li Q; Bao JM; Li XL; Zhang T; Shen XH
    Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
    Guo SW; Du Y; Liu X
    Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+CD25+Foxp3+ regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood.
    Geng X; Li M; Cui B; Lu C; Liu X; Zhang P; Liu B; Ma C; Shen Y; Lu Z
    Medicine (Baltimore); 2019 May; 98(22):e15722. PubMed ID: 31145286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway.
    Zhong H; Lai Y; Zhang R; Daoud A; Feng Q; Zhou J; Shang J
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
    Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
    Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.